Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Form 8 (DD) - DBAY Advisors Limited

19 Oct 2018 11:49

RNS Number : 6317E
DBAY Advisors Limited
19 October 2018
 

FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Power of Talent Ltd, a newly incorporated company owned and controlled by funds under the discretionary management of DBAY Advisors Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Nomura PB Nominees Ltd and Credit Suisse AG Dublin Branch for funds under the discretionary management of DBAY Advisors Limited

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Harvey Nash Group Plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

OFFEROR

(e) Date dealing undertaken:

18 October 2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

30,022,738

40.87%

None

None

(2) Cash-settled derivatives:

 

None

None

None

None

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

None

None

None

None

 

TOTAL:

 30,022,738

40.87%

None

None

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

Ordinary shares

 

Purchase

 

 1,006,561

 

GBP 1.30

 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

19 October 2018

 

Contact name:

Mike Haxby, Operations, DBAY Advisors Limited

Telephone number:

+44 (0) 1624 690900

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DCCFKCDQKBDDAKD
Date   Source Headline
3rd Jun 20131:21 pmRNSHolding(s) in Company
31st May 20137:00 amRNSInterim Management Statement
31st May 20137:00 amRNSTotal Voting Rights
28th May 20135:27 pmRNSNotice of AGM
28th May 20131:02 pmRNSDirector/PDMR Shareholding
17th May 20136:08 pmRNSHolding(s) in Company
13th May 20134:15 pmRNSHolding(s) in Company
13th May 20132:55 pmRNSDirector/PDMR Shareholding
13th May 20132:55 pmRNSDirector/PDMR Shareholding
2nd May 20134:32 pmRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSTotal Voting Rights
30th Apr 20134:29 pmRNSEBT Share Purchase
30th Apr 20137:02 amRNSDirectorate Appointment
30th Apr 20137:01 amRNSRegarding Acquisition
30th Apr 20137:00 amRNSHarvey Nash Joint Venture
30th Apr 20137:00 amRNSFinal Results
26th Apr 20135:44 pmRNSDirector/PDMR Shareholding
2nd Apr 20137:00 amRNSTotal Voting Rights
26th Mar 20133:32 pmRNSDirector/PDMR Shareholding
1st Mar 20137:00 amRNSTotal Voting Rights
28th Feb 20139:19 amRNSHolding(s) in Company
27th Feb 20135:08 pmRNSDirector/PDMR Shareholding
13th Feb 20137:00 amRNSPre-close trading update
31st Jan 20137:00 amRNSTotal Voting Rights
28th Jan 20134:42 pmRNSDirector/PDMR Shareholding
22nd Jan 20139:00 amRNSBusiness Leaders Tackle Gender Imbalance on Boards
8th Jan 20134:12 pmRNSHolding(s) in Company
8th Jan 201312:14 pmRNSHolding(s) in Company
31st Dec 20127:00 amRNSTotal Voting Rights
24th Dec 20128:21 amRNSDirector/PDMR Shareholding
14th Dec 20127:00 amRNSDirectorate Change
12th Dec 20127:00 amRNSBlocklisting Interim Review
30th Nov 20123:58 pmRNSDirector/PDMR Shareholding
30th Nov 20127:00 amRNSInterim Management Statement
30th Nov 20127:00 amRNSTotal Voting Rights
8th Nov 20121:11 pmRNSHolding(s) in Company
1st Nov 20127:00 amRNSTotal Voting Rights
30th Oct 20121:14 pmRNSDirector/PDMR Shareholding
29th Oct 20122:44 pmRNSDirector/PDMR Shareholding
18th Oct 20124:11 pmRNSEBT Share Purchase
17th Oct 20123:18 pmRNSDirector/PDMR Shareholding
1st Oct 20129:18 amRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSTotal Voting Rights
28th Sep 20127:00 amRNSHalf Yearly Report
31st Aug 20124:48 pmRNSDirector/PDMR Shareholding
31st Aug 20127:00 amRNSTotal Voting Rights
13th Aug 20127:00 amRNSTrading Statement
1st Aug 20127:00 amRNSTotal Voting Rights
30th Jul 20124:50 pmRNSDirector/PDMR Shareholding
17th Jul 201212:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.